Protagonist Therapeutics (PGF) Q3 2018 Earnings Report
DE:PGF Q3 2018 EPS Results
- Actual EPS
- -EUR 0.34
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.26
DE:PGF Q3 2018 Revenue Results
- Actual Revenue
- EUR 5.47M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2018
- Date
- 11/06/2018
- Time
- After Close
- Conference Call
- Tuesday, November 6, 2018
DE:PGF Upcoming Earnings
Protagonist Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q3 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:PGF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | 2.24- | -0.55 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | 1.982.05 | -0.49 | 516.36% (+2.54) | |
| May 05, 2026 | 2026 (Q1) | -0.420.04 | -0.17 | 126.32% (+0.21) | |
| Feb 25, 2026 | 2025 (Q4) | -0.51-0.62 | 1.77 | -134.85% (-2.39) | |
| Nov 06, 2025 | 2025 (Q3) | -0.56-0.55 | -0.48 | -14.81% (-0.07) | |
| Aug 06, 2025 | 2025 (Q2) | -0.52-0.49 | -0.45 | -10.00% (-0.04) | |
| Apr 30, 2025 | 2025 (Q1) | -0.17-0.17 | 2.91 | -105.67% (-3.08) | |
| Feb 21, 2025 | 2024 (Q4) | 1.031.77 | 0.39 | 350.00% (+1.38) | |
| Nov 07, 2024 | 2024 (Q3) | -0.52-0.48 | -0.52 | 6.90% (+0.04) | |
| Aug 06, 2024 | 2024 (Q2) | -0.53-0.45 | -0.61 | 26.47% (+0.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
